Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $225.2M $187.3M $159.0M $138.6M $127.4M $112.3M $106.7M $83.9M
Cost of Revenue $57.9M $45.4M $37.1M $29.8M $22.9M $21.6M $17.3M $12.9M
Gross Profit $167.4M $142.0M $121.9M $108.8M $104.4M $90.7M $89.4M $71.0M
Gross Margin 74.3% 75.8% 76.6% 78.5% 82.0% 80.8% 83.7% 84.6%
Operating Expenses
Research & Development $32.9M $27.8M $27.3M $25.6M $24.2M $17.8M $17.5M $11.8M
SG&A Expense $44.6M $39.0M $38.4M $40.9M $32.3M $26.4M $31.3M $23.1M
Operating Income $-7.8M $-3.3M $-21.5M $-29.7M $-25.4M $-23.2M $-31.4M $-20.5M
Operating Margin -3.5% -1.8% -13.5% -21.4% -20.0% -20.6% -29.4% -24.4%
Interest Expense $2.8M $624.0K $1.4M $1.1M $40.0K $1.2M
Pretax Income
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $-15.7M $-10.0M $-21.7M $-28.9M $-27.0M $-23.8M $-29.1M $-22.4M
Net Margin -7.0% -5.3% -13.7% -20.9% -21.2% -21.2% -27.3% -26.7%
EPS (Basic) $-0.34 $-0.23 $-0.51 $-0.69 $-0.65 $-0.60 $-0.74 $-0.60
EPS (Diluted) $-0.34 $-0.23 $-0.51 $-0.69 $-0.65 $-0.60 $-0.74 $-0.60
Shares Outstanding (Basic) 46.1M 44.3M 42.9M 42.1M 41.2M 40.0M 39.2M 38.9M
Shares Outstanding (Diluted) 46.1M 44.3M 42.9M 42.1M 41.2M 40.0M 39.2M 38.9M
Dividends Per Share
← Newer Page 1 of 2 Older →